Brief: Avenue Therapeutics Announces Pricing Of $5.0 Million Public Offering
Oct 31 (Reuters) - Avenue Therapeutics Inc ATXI.O :
* AVENUE THERAPEUTICS ANNOUNCES PRICING OF $5.0 MILLION
PUBLIC
OFFERING
* PRICING OF ITS PUBLIC OFFERING OF AN AGGREGATE OF
16,633,400
UNITS AT A PUBLIC OFFERING PRICE OF $0.3006 PER UNIT
Source text for Eikon: ID:nGNXch4gBR
Further company coverage: ATXI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avenue Therapeutics
See all newsBrief: Axsome Therapeutics Acquires AZD7325, A Selective GABA-A Modulator For Treatment Of Epilepsy
Avenue Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Avenue Therapeutics Annji Intends To Terminate License Agreement With Co
Brief: Avenue Therapeutics Receives Delist Letter From Nasdaq Under Nasdaq Listing Rule 5550(B)(1)
Avenue Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary